Anti-Aging & LongevityOncology & Cancer CarePerformance & Hormone OptimizationPharma
Jaknat 10mg Tablets | 100-Count | RUXOLITINIB
$180
In stock
For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse RUXOLITINIB — 10mg per tablet, 100-count pack. JAK1/JAK2 inhibitor for myelofibrosis, polycythemia vera, graft-versus-host disease, and alopecia areata. Jakavi brand most widely available internationally. Key warning: Dose reduction in hepatic/renal impairment. TB screening before starting. Live vaccines contraindicated. Gradual tapering required. Interrupt for serious infections.
JAK1/JAK2 inhibitor for myelofibrosis, polycythemia vera, graft-versus-host disease, and alopecia areata. Jakavi brand most widely available internationally.
How it Works
Inhibits JAK1/JAK2 in the JAK/STAT pathway — reduces pro-inflammatory cytokine signaling and abnormal hematopoietic cell proliferation.
Quick Specs
Form
Oral tablets — pre-dosed
Active Ingredient
RUXOLITINIB
Dose per Tablet
10MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)
Common Side Effects
Anemia, thrombocytopenia, neutropenia, infections, weight gain, bruising, non-melanoma skin cancer risk.
Safety Warnings
Dose reduction in hepatic/renal impairment. TB screening before starting. Live vaccines contraindicated. Gradual tapering required. Interrupt for serious infections. International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
